Provided by Tiger Fintech (Singapore) Pte. Ltd.

BKV Corp.

17.99
-0.6100-3.28%
Pre-market: 18.430.4400+2.45%06:12 EDT
Volume:273.12K
Turnover:4.95M
Market Cap:1.52B
PE:-8.98
High:18.30
Open:18.27
Low:17.94
Close:18.60
Loading ...

U.S. RESEARCH ROUNDUP-Amazon, Ford, Netflix

Reuters
·
16 Dec 2024

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
10 Dec 2024

US natgas producers chase AI-driven surge in power demand to weather low prices

Reuters
·
21 Nov 2024

Range Resources, BKV new longs ideas at Hedgeye

seekingalpha
·
21 Nov 2024

Barclays Sticks to Its Buy Rating for BKV Corporation (BKV)

TIPRANKS
·
20 Nov 2024

BKV Is Maintained at Buy by Truist Securities

Dow Jones
·
19 Nov 2024

Truist Lifts Price Target on BKV to $25 From $24, Maintains Buy Rating

MT Newswires Live
·
19 Nov 2024

BKV Corp. price target raised to $25 from $24 at Truist

TIPRANKS
·
19 Nov 2024

Press Release: Vera Therapeutics Appoints Jason S. Carter as Chief Legal Officer

Dow Jones
·
18 Nov 2024

Analysts Have Conflicting Sentiments on These Energy Companies: Occidental Petroleum (OXY), EnLink Midstream (ENLC) and BKV Corporation (BKV)

TIPRANKS
·
14 Nov 2024

Venture Global LNG plans to raise $3 bln from US IPO, sources say

Reuters
·
14 Nov 2024

Positive Outlook for BKV Corporation Driven by Strategic Initiatives and Strong Third-Quarter Performance

TIPRANKS
·
13 Nov 2024

BKV Corporation’s First Public Earnings Report

TIPRANKS
·
13 Nov 2024

BKV's Q3 Non-GAAP Loss Widens, Revenue Falls

MT Newswires Live
·
12 Nov 2024

BKV: Q3 Earnings Snapshot

Associated Press Finance
·
12 Nov 2024

Press Release: BKV Corporation Reports Third Quarter 2024 Financial and Operational Results

Dow Jones
·
12 Nov 2024

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
12 Nov 2024

Vera Therapeutics Partners with University of Michigan on the NEPTUNE Match Project and PIONEER Study

GlobeNewswire
·
11 Nov 2024

Vera Therapeutics to Participate at Upcoming Investor Conferences

GlobeNewswire
·
08 Nov 2024

Press Release: Vera Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results

Dow Jones
·
07 Nov 2024